![PROSTATE CANCER RISK CALCULATOR COMPARISON: IPCRC vs KPCRC vs PCPT-RC vs ERSPC-RC IN PREDICTING PROSTATE CANCER AT HASAN SADIKIN HOSPITAL | Indonesian Journal of Urology PROSTATE CANCER RISK CALCULATOR COMPARISON: IPCRC vs KPCRC vs PCPT-RC vs ERSPC-RC IN PREDICTING PROSTATE CANCER AT HASAN SADIKIN HOSPITAL | Indonesian Journal of Urology](https://juri.urologi.or.id/public/journals/1/cover_issue_38_en_US.jpg)
PROSTATE CANCER RISK CALCULATOR COMPARISON: IPCRC vs KPCRC vs PCPT-RC vs ERSPC-RC IN PREDICTING PROSTATE CANCER AT HASAN SADIKIN HOSPITAL | Indonesian Journal of Urology
![Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators - European Urology Focus Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/8e34ab0e-8920-4a8b-9c25-cdeb06947907/gr1_lrg.jpg)
Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators - European Urology Focus
![4kscore test, prostate cancer prevention trial-risk calculator y european research screening prostate-risk calculator en la predicción del cáncer de próstata de alto grado; estudio preliminar - Repositorio Institucional de Documentos 4kscore test, prostate cancer prevention trial-risk calculator y european research screening prostate-risk calculator en la predicción del cáncer de próstata de alto grado; estudio preliminar - Repositorio Institucional de Documentos](https://zaguan.unizar.es/record/78052/files/texto_completo.jpg?subformat=icon)
4kscore test, prostate cancer prevention trial-risk calculator y european research screening prostate-risk calculator en la predicción del cáncer de próstata de alto grado; estudio preliminar - Repositorio Institucional de Documentos
![Cells | Free Full-Text | Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer Cells | Free Full-Text | Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer](https://www.mdpi.com/cells/cells-09-02116/article_deploy/html/images/cells-09-02116-g001.png)
Cells | Free Full-Text | Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer
![Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI](https://www.bjuinternational.com/wp-content/uploads/2016/11/AOTWNov2.jpg)
Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI
![Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS) | SpringerLink Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00345-017-2150-1/MediaObjects/345_2017_2150_Fig2_HTML.gif)
Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS) | SpringerLink
![A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer - European Urology Oncology A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer - European Urology Oncology](https://euoncology.europeanurology.com/cms/asset/582a732d-abcf-418b-836b-aec1dc587797/gr1.jpg)
A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer - European Urology Oncology
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/34fd32696f2b1472725b338fc204d29585f2fe93/5-Figure2-1.png)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar
Prediction of significant prostate cancer in biopsy-naïve men: Validation of a novel risk model combining MRI and clinical parameters and comparison to an ERSPC risk calculator and PI-RADS | PLOS ONE
![Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.](https://d3i71xaburhd42.cloudfront.net/cfb41af6cecfb5f204e79875232cee8734801010/3-Table3-1.png)
Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
![JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy](https://pub.mdpi-res.com/jpm/jpm-09-00019/article_deploy/html/images/jpm-09-00019-g001.png?1571415812)
JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy
![CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2011/06/capra-s-rev.png?w=640)
CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK
![External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - European Urology Focus External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/1c9dc49e-b7f0-494a-8696-a6fff2ae90ed/gr2_lrg.jpg)
External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - European Urology Focus
![Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort - European Urology Focus Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/db29479a-a44f-4bde-a7d1-637d2436e8ee/gr1_lrg.jpg)
Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort - European Urology Focus
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283812008342-gr2.jpg)